Open AccessCYP2C19 Genotyping Plus Therapeutic Drug Monitoring Dependent Voriconazole Treatment for Invasive Pulmonary Aspergillosis in a Patient with Liver Failure
Author(s) -
Chuan Shen,
Qian Zhao,
Ziyue Li,
Wei Wang,
Yalin Zhao,
Lingya Kong,
Jing Xie,
Caiyan Zhao
Publication year - 2022
Publication title -
infectious diseases and immunity
Language(s) - English
Resource type - Journals
eISSN - 2693-8839
pISSN - 2096-9511
DOI - 10.1097/id9.0000000000000036
Subject(s) - voriconazole , medicine , cyp2c19 , therapeutic drug monitoring , aspergillosis , tolerability , context (archaeology) , intensive care medicine , gastroenterology , adverse effect , pharmacokinetics , immunology , dermatology , cytochrome p450 , antifungal , biology , metabolism , paleontology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom